Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Aridis Pharmaceuticals, Inc. (ARDS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 11/21/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 11/10/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/12/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/11/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/30/2021 |
10-Q/A
| Quarterly Report for the period ended March 31, 2020 [amend] |
| 11/23/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 08/11/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 05/12/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
| 11/13/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 08/12/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 05/14/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 11/14/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 09/26/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
|
|